Susquehanna International Group (Ireland)’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
$988K Hold
10,000
0.21% 44
2024
Q2
$927K Sell
10,000
-290
-3% -$26K 0.23% 42
2024
Q1
$976K Buy
+10,290
New +$955K 0.23% 45

Other funds holding XBI

Susquehanna International Group (Ireland)'s XBI Position: Q3 2024 in Review

Susquehanna International Group (Ireland) held its State Street SPDR S&P Biotech ETF (XBI) position steady in Q3 2024 at 10,000 shares worth $988K. The position accounts for 0.21% of the portfolio, ranked #44.

Susquehanna International Group (Ireland) first reported a position in XBI in Q1 2024 and has held it in 3 quarters since. 769 funds tracked by Wall St. Rank hold XBI as of Q3 2024.

  • Susquehanna International Group (Ireland) held 10,000 shares of State Street SPDR S&P Biotech ETF worth $988K as of Q3 2024.
  • Susquehanna International Group (Ireland) left its State Street SPDR S&P Biotech ETF share count unchanged in Q3 2024.
  • State Street SPDR S&P Biotech ETF made up 0.21% of Susquehanna International Group (Ireland)'s portfolio in Q3 2024, its #44 holding.
  • Susquehanna International Group (Ireland) first reported a position in State Street SPDR S&P Biotech ETF in Q1 2024 and has held it in 3 quarters since.
  • 769 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q3 2024.

Based on Susquehanna International Group (Ireland)'s 13F filing for Q3 2024, filed 14 Nov 2024.